Voluntary deep inspiration breath-hold reduces the heart dose without compromising the target volume coverage during radiotherapy for left-sided breast cancer
, , , , , , , , et | 23 févr. 2018
À propos de cet article
Article Category: Research Article
Publié en ligne: 23 févr. 2018
Pages: 112 - 120
Reçu: 26 oct. 2017
Accepté: 15 janv. 2018
DOI: https://doi.org/10.1515/raon-2018-0008
© 2018 Noora Al-Hammadi, Palmira Caparrotti, Carole Naim, Jillian Hayes, Katherine Rebecca Benson, Ana Vasic, Hissa Al-Abdulla, Rabih Hammoud, Saju Divakar, Primoz Petric
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Noora Al-Hammadi
Department of Radiation Oncology,
National Center for Cancer Care and Research, Hamad Medical Corporation
Doha, Qatar
Palmira Caparrotti
Department of Radiation Oncology,
National Center for Cancer Care and Research, Hamad Medical Corporation
Doha, Qatar
Carole Naim
Department of Radiation Oncology,
National Center for Cancer Care and Research, Hamad Medical Corporation
Doha, Qatar
Jillian Hayes
Department of Radiation Oncology,
National Center for Cancer Care and Research, Hamad Medical Corporation
Doha, Qatar
Katherine Rebecca Benson
Department of Radiation Oncology,
National Center for Cancer Care and Research, Hamad Medical Corporation
Doha, Qatar
Ana Vasic
Department of Radiation Oncology,
National Center for Cancer Care and Research, Hamad Medical Corporation
Doha, Qatar
Hissa Al-Abdulla
Department of Radiation Oncology,
National Center for Cancer Care and Research, Hamad Medical Corporation
Doha, Qatar
Rabih Hammoud
Department of Radiation Oncology,
National Center for Cancer Care and Research, Hamad Medical Corporation
Doha, Qatar
Saju Divakar
Department of Radiation Oncology,
National Center for Cancer Care and Research, Hamad Medical Corporation
Doha, Qatar
Primoz Petric
Department of Radiation Oncology,
National Center for Cancer Care and Research, Hamad Medical Corporation
Doha, Qatar